Crown Castle (CCI)
NYSEReal EstateReit - SpecialtySnapshot 2026-09-04
$75.83-1.85%
Close 2026-09-04 · 1-day change
NYSEReal EstateReit - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · CCI
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 7 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $76 CCI trades at 21× p/ffo — 1.6× the 13× p/ffo peer median. The market is re-rating it beyond its own range; our $83 fair value is medium-confidence here. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcff | 12M | $154.85 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $60.53 | — | — | TTM | high |
| Peer P/FCF | 12M | $86.33 | 15.6 | 5.54 | TTM | high |
| Peer P/FFO | 12M | $47.17 | 13.2 | 3.57 | TTM | high |
| Peer P/S | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
No fragility gates fired.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Cheaper than its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $36.72 |
| 3.8 |
| 9.59 |
| TTM |
| high |
| Own P/E history | 12M | $95.94 | 33.1 | 2.90 | TTM | high |
| triangulated | 12M | $41.08 | 13.2 | 3.11 | Triangulated | high |
| Peer P/FCF | 3Y | $114.13 | 15.6 | 7.33 | Hist. CAGR(prov.) | medium |
| Peer P/FFO | 3Y | $21.25 | 13.2 | 1.61 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $29.55 | 3.8 | 7.72 | guidance | medium |
| Own P/E history | 3Y | $88.43 | 33.1 | 2.67 | Analyst | medium |
| Peer P/FCF | 5Y | $137.47 | 15.6 | 8.83 | Hist. CAGR(prov.) | medium |
| Peer P/FFO | 5Y | $12.49 | 13.2 | 0.95 | Hist. CAGR(prov.) | medium |
| Peer P/S | 5Y | $25.57 | 3.8 | 6.68 | guidance | medium |
| Own P/E history | 5Y | $83.76 | 33.1 | 2.53 | Analyst | medium |